Evidence map›Paper›PMID 41258334›Full record

SynthesisClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Gastric cancer burden and regional disparities among Helicobacter pylori-positive patients in the Americas: a systematic review and meta-analysis.

Francisco Cezar Aquino de Moraes, Luis Eduardo Rodrigues Sobreira, Nuris Maria Torres Argota, Emanuele Rocha da Silva, Gustavo Tadeu Freitas Uchôa Matheus, Rommel Mario Rodríguez Burbano

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Mastitis as a risk factor for breast cancer: a systematic review and meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Pooled it
  2. Quantitative Microbial Risk Assessment ofFoods (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Francisco Cezar Aquino de MoraesHuman Cytogenetics Laboratory, Federal University of Pará, Belém, Pará, 66073-005, Brazil. francisco.cezar2205@gmail.com.ORCID http://orcid.org/0000-0003-0623-8135
Luis Eduardo Rodrigues SobreiraFederal University of Pará, Altamira, Pará, 68371-040, Brazil.ORCID http://orcid.org/0009-0003-3006-5489
Nuris Maria Torres ArgotaSanta Casa de Misericórdia Hospital in Porto Alegre, Porto Alegre, RS, 90020-090, Brazil.
Emanuele Rocha da SilvaHuman Cytogenetics Laboratory, Federal University of Pará, Belém, Pará, 66073-005, Brazil.ORCID http://orcid.org/0000-0002-9109-4158
Gustavo Tadeu Freitas Uchôa MatheusFederal University of Triângulo Mineiro, Uberaba, MG, 38025440, Brazil.ORCID http://orcid.org/0009-0005-8707-4823
Rommel Mario Rodríguez BurbanoHuman Cytogenetics Laboratory, Federal University of Pará, Belém, Pará, 66073-005, Brazil.ORCID http://orcid.org/0000-0002-4872-234X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHelicobacter pylori infection is a significant risk factor for gastric cancer (GC), particularly in populations across the Americas. Previous studies have suggested a link between HP and GC, but variability in prevalence across regions has yet to be fully explored. The aim of this study is to quantify the prevalence of GC in HP-positive patients across the Americas, identifying disparities by country, region, and demographic factors.

methodsThe study followed the PRISMA guidelines and was registered with PROSPERO (CRD42024585790). A systematic search of PubMed, Scopus, LILACS/BVS, and Web of Science databases was conducted until August 20, 2024. Eligibility criteria included studies with patients aged 18 years or older, with confirmed diagnosis of gastric cancer, and H. pylori infection status. Risk of success was assessed using the Newcastle-Ottawa Scale, and publication success was assessed using the Egger test. Pooled prevalence was calculated using a meta-analysis of proportions with a random-effects model, and heterogeneity was assessed using the I

resultsFifty-nine studies, with 5,734,656 patients (134,755 HP-positive), met the inclusion criteria. The overall prevalence of GC in HP-positive patients in the Americas was 25.56% (95% CI: 20.72-30.40), with high heterogeneity (I2 = 100%, p < 0.05). South America showed a higher prevalence (27.66%, 95% CI: 22.36-32.96) than North America (23.47%, 95% CI: 20.72-30.40). Peru had the highest prevalence at 52.11%, followed by Chile (50.94%) and Honduras (45.62%); Colombia and the United States showed lower rates, at 15.65% and 23.02%, respectively.

conclusionThis meta-analysis highlights a significant GC prevalence among HP-positive patients in the Americas, with marked variability between countries.

Indexed as

Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAmericasHumansPrevalenceRisk FactorsAmericasGastric cancerHelicobacter pyloriMeta-analysisPrevalencePublic health disparities

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.